MDS,AML,WorldAMLAwarenessDay

Mashup Score: 0

New Adverse Events Highlight Safety Concerns With Azacitidine - Oncology Nurse Advisor - 9 day(s) ago

An analysis of 2 pharmacovigilance databases revealed a high prevalence of azacitidine-related adverse events in patients with MDS or AML.

Source: www.oncologynurseadvisor.com

Categories: General Medicine News

Tweet Tweets with this article
- ONAcom
  
  The use of azacitidine in treating #MDS and #AML is well established; however, a need for heightened clinical vigilance due to the emergence of several potentially unreported AEs exists. Published in @FrontPharmacol. https://t.co/zOMOHBLjdq #WorldAMLAwarenessDay